Protein Z levels and central retinal vein or artery occlusion

European Journal of Haematology

Volumn 75, Issue 5, 2005, Pages 401-405

  Koren Michowitz, Maya ^a   Eting, Eva ^a   Rahimi Levene, Naomi ^a   Garach Jehoshua, Osnat ^a   Volcheck, Yulia ^a   Kornberg, Abraham ^a  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

Central retinal artery occlusion; Central retinal vein occlusion; Protein Z; Thrombosis

Indexed keywords

ACTIVATED PROTEIN C; CARDIOLIPIN ANTIBODY; FATTY ACID BINDING PROTEIN; LUPUS ANTICOAGULANT;

ACTIVATED PROTEIN C RESISTANCE; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CENTRAL RETINA ARTERY OCCLUSION; CENTRAL RETINA VEIN OCCLUSION; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR;

ADULT; AGED; BLOOD PROTEINS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; RETINAL ARTERY OCCLUSION; RETINAL VEIN OCCLUSION; RISK FACTORS;

EID: 26844464644     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2005.00529.x     Document Type: Article

References (21)

1. BROZE GJ Jr. Protein Z-dependent regulation of coagulation. Thromb Haemost 2001;86:8-13.
2. BROZE GJ JR. Protein-Z and thrombosis. Lancet 2001;357:900-901 (comment).
3. VASSE M, GUEGAN-MASSARDIER E, BORG JY, WOIMANT F, SORIA C. Frequency of protein Z deficiency in patients with ischaemic stroke. Lancet 2001;357:933-934 (letter).
4. HEEB MJ, PAGANINI-HILL A, GRIFFIN JH, FISHER M. Low protein Z levels and risk of ischemic stroke: differences by diabetic status and gender. Blood Cells Mol Dis 2002;29:139-144.
5. KOBELT K, BIASIUTTI FD, MATTLE HP, LAMMLE B, WUILLEMIN WA. Protein Z in ischaemic stroke. Br J Haematol 2001;114:169-173.
6. LOPACIUK S, BYKOWSKA K, KWIECINSKI H, CZLONKOWSKA A, KUCZYNSKA- ZARDZEWIALY A. PROTEIN Z in young survivors of ischemic stroke. Thromb Haemost 2002;88:536 (Letter).
7. FEDI S, SOFI F, BROGI D, TELLINI I, CESARI F, SESTINI I, GAZZINI A, COMEGLIO M, ABBATE R, GENSINI GF. Low protein Z plasma levels are independently associated with acute coronary syndromes. Thromb Haemost 2003;90:1173-1178.
8. FORASTIERO RR, MARTINUZZO ME, LU L, BROZE GJ. Autoimmune antiphospholipid antibodies impair the inhibition of activated factor X by protein Z/protein Z-dependent protease inhibitor. J Thromb Haemost 2003;1:1764-1770.
9. KEMKES-MATTHES B, NEES M, KUHNEL G, MATZDORFF A, MATTHES KJ. Protein Z influences the prothrombotic phenotype in Factor V Leiden patients. Thromb Res 2002;106:183-185.
10. FEGAN CD. Central retinal vein occlusion and thrombophilia. Eye 2002;16:98-106.
11. PRISCO D, MARCUCCI R, BERTINI L, GORI AM. Cardiovascular and thrombophilic risk factors for central retinal vein occlusion. Eur J Intern Med 2002;13:163-169.
12. KOUTROUBAKIS IE, THEODOROPOULOU A, SFIRIDAKI A, KOUROUMALIS EA. Low plasma protein Z levels in patients with ischemic colitis. Dig Dis Sci 2003;48:1673-1676.
13. GRIS JC, QUERE I, DECHAUD H, MERCIER E, PINCON C, HOFFET M, VASSE M, MARES P. High frequency of protein Z deficiency in patients with unexplained early fetal loss. Blood 2002;99:2606-2608.
14. PAIDAS MJ, KU DHW, ARKEL YS, et al. First trimester maternal protein Z levels are lower in patients with complicated pregnancies and patients with thrombophilia and subsequent adverse pregnancy outcomes. Blood 2002;100:267a (abstract).
15. MILETICH JP, BROZE GJ Jr. Human plasma protein Z antigen: range in normal subjects and effect of warfarin therapy. Blood 1987;69:1580-1586.
16. SANTACROCE R, CAPPUCCI F, DI PERNA P, SESSA F, MARGAGLIONE M. Protein Z gene polymorphisms are associated with protein Z plasma levels. J Thromb Haemost 2004;2:1197-1199.
17. LICHY C, KROPP S, DONG-SI T, GENIUS J, DOLAN T, HAMPE T, STOLL F, REUNER K, GROND-GINSBACH C, GRAU A. A common polymorphism of the protein Z gene is associated with protein Z plasma levels and with risk of cerebral ischemia in the young. Stroke 2004;35:40-45.
18. BERTOLINO G, MONTANI N, LORENZUTTI F, BALDUINI CL, GAMBA G. Behaviour of plasma protein Z levels in patients with abnormal haemostasis: correlations with coagulation screening tests. Thromb Haemost 1997;78(Suppl. 1):235a (abstract). 7
19. GRIS JC, AMADIO C, MERCIER E, LAVIGNE-LISSALD E G, DÉCHAUD H, HOFFET M, QUÉRÉ I, AMIRAL J, DAUZAT M, MARES P. Anti-protein Z antibodies in women with pathologic pregnancies. Blood 2003;101:4850-4852.
20. VAN DE WATER N, TAN T, ASHTON F, O'GRADY A, DAY T, BROWETT P, OCKELFORD P, HARPER P. Mutations within the protein Z-dependent protease inhibitor gene are associated with venous thromboembolic disease: a new form of thrombophilia. BJH 2004;127:190-194.
21. GRETEN J, KREIS I, LILIENSIEK B, ALLENBERG J, AMIRAL J, ZIEGLER R, NAWROTH PP. Localisation of protein Z in vascular lesions of patients with atherosclerosis. Vasa 1998;27:144-148.